Shandong Sanyuan Biotechnology (301206.SZ) has issued a profit forecast, with an expected annual net profit of 95 million to 120 million yuan, a year-on-year increase of 61.36% to 103.82%.

Shandong Sanyuan Biotechnology (301206.SZ) disclosed its performance forecast for 2024, with the company expecting a net profit attributable to shareholders of the listed company of 95 million to 120 million yuan, an increase of 61.36% to 103.82% year-on-year; the net profit after deducting non-recurring gains and losses is expected to be 92.85 million to 118 million yuan, an increase of 60.97% to 104.31% year-on-year.